Content about Amneal Pharmaceuticals

March 5, 2013
Amneal ships opioid-dependence drug

Amneal Pharmaceuticals has started shipping a drug used to treat opioid dependence, the company said Tuesday.

February 25, 2013
FDA approves Amneal opioid-dependence drug

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a drug to treat opioid dependence.

February 21, 2013
GPhA appoints board of directors for 2013

The Generic Pharmaceutical Association re-elected its chairman from last year and appointed a new board of directors for 2013 whose members run from A to Z — as in Amneal to Zydus.

January 28, 2013
Amneal, South Korea-based Hanmi enter GERD drug deal

U.S. generic drug maker Amneal Pharmaceuticals has entered a deal with South Korean drug maker Hanmi Pharmaceutical to acquire exclusive distribution rights for a Hanmi drug used for treating gastroesophageal reflux disease, Amneal said Monday.

September 18, 2012
NewsBytes — Generics, 9/24/12

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


August 6, 2012
Amneal plans $120 million expansion

Generic drug maker Amneal Pharmaceuticals will spend $120 million to expand three of its plants, the company said Monday.

May 16, 2012
Amneal adds blackberry flavoring to generic diabetes drug

Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.

March 15, 2012
Amneal launches liquid generic Lexapro

Amneal Pharmaceuticals has launched a generic version of an antidepressant made by Forest Labs.

December 22, 2011
Amneal launches felbamate oral suspension

Amneal Pharmaceuticals has launched its generic version of a drug designed to treat seizures in adults and children with epilepsy.

December 13, 2011
Amneal makes new executive appointments

Generic drug maker Amneal Pharmaceuticals has added four new executives, the company said.

July 5, 2011
Amneal's president, CEO win Ernst & Young Entrepreneur of the Year award

Chirag Patel and Chintu Patel, who respectively are the president and CEO of Amneal Pharmaceuticals, recently received the Ernst & Young Entrepreneur of the Year award.

July 5, 2011
Shire files suit against Amneal, Sandoz over generic Vyvanse

Shire has filed patent infringement suits against two generic drug makers relating to its attention deficit hyperactivity disorder treatment.

June 20, 2011
ReportersNotebook — Chain Pharmacy, 6/27/11

A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.

May 23, 2011
Amneal to manufacture generic Furadantin

A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.

March 3, 2011
Amneal receives FDA approval for generic Indocin

The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.

December 9, 2010
Amneal names SVP, general counsel

Amneal Pharmaceuticals has named a drug industry attorney as SVP and general counsel, the generic drug maker said Thursday.

August 26, 2010
FDA approves Amneal generic for treatment of hypertension and liver cirrhosis

The Food and Drug Administration has approved a generic treatment for hypertension and liver cirrhosis...

July 12, 2010
Hariharan joins Amneal

Generic drug maker Amneal Pharmaceuticals has appointed a former Par Pharmaceutical Cos. executive as chief...

June 15, 2010
FDA approves generic Lorazepam Intensol

The Food and Drug Administration has approved a generic drug for anxiety disorder made by...

May 11, 2010
Amneal expands sales, distribution in Kentucky

Generic drug maker Amneal Pharmaceuticals plans to invest more than $6.6 million in its sales...

© 2013 Drug Store News. All Rights Reserved.